XML 23 R12.htm IDEA: XBRL DOCUMENT v3.24.3
Note 6 - Stock Based Compensation
 9 Months Ended
Sep. 30, 2024
Notes to Financial Statements  
Share-Based Payment Arrangement [Text Block]

Note 6 - Stock Based Compensation

 

2019 Equity Incentive Plan

 

On December 19, 2019, the Oblong, Inc. 2019 Equity Incentive Plan (the “2019 Plan”) was approved by the Company’s stockholders at the Company’s 2019 Annual Meeting of Stockholders. The 2019 Plan is an omnibus equity incentive plan pursuant to which the Company may grant equity and cash incentive awards to certain key service providers of the Company and its subsidiaries. As of  December 31, 2023 and September 30, 2024, there were no remaining shares in the share pool available for new grants under the 2019 Plan.

 

Stock Options

 

A summary of stock option activity under our plans, and options outstanding as of, and changes made during the nine months ended September 30, 2024 and year ended December 31, 2023 is presented below:

 

  

Outstanding

  

Exercisable

 
  

Number of Options

  

Weighted Average Exercise Price

  

Number of Options

  

Weighted Average Exercise Price

 

Options outstanding and exercisable, December 31, 2022

  417  $5,744.82   250  $8,274.91 

Vested

  —   —   83   1,950.00 

Expired

  (167)  11,435.60   (167)  11,435.60 

Options outstanding and exercisable, December 31, 2023

  250   1,950.00   166   1,950.00 

Vested

  —   —   84   1,950.00 

Options outstanding and exercisable, September 30, 2024

  250  $1,950.00   250  $1,950.00 

 

The intrinsic value of vested and unvested options was not significant for all periods presented. Stock compensation expense related to stock options for the three months ended September 30, 2024 and 2023 was zero and $31,000, respectively. Stock compensation expense related to stock options for the nine months ended September 30, 2024 and 2023 was $62,000 and $93,000, respectively. The stock compensation expense was included as a general and administrative expense on our Condensed Consolidated Statements of Operations. As of September 30, 2024 there is no remaining unamortized stock compensation expense.

 

Restricted Stock

 

As of September 30, 2024 and December 31, 2023, there were no outstanding restricted stock awards ("RSAs") or restricted stock units (“RSUs,” collectively "Restricted Stock"). There was no Restricted Stock activity or expense for the three and nine months ended September 30, 2024. During the nine months ended September 30, 2023, in relation to the departure of certain board members, 2 RSAs became fully vested. The 2 RSAs, along with 49 previously vested RSUs, were delivered in shares of the Company's Common Stock in accordance with the terms of the agreements. This Restricted Stock was issued in 2014 and had been fully expensed, so there was no stock compensation expense related to Restricted Stock for nine months ended September 30, 2023. During the nine months ended September 30, 2023, 4,440 RSUs were granted to certain board members. These RSU's vested immediately upon issuance and the stock compensation related to RSUs for the nine months ended September 30, 2023 was $380,000, which was included in general and administrative expense on our Condensed Consolidated Statements of Operations.